Du er her:
» David Brooks
David Brooks
Professor
Professor
Institut for Klinisk Medicin - Nuklearmedicin og PET
Postaddresse:
Palle Juul-Jensens Boulevard 165
Cross point J119-149
8200
Aarhus N
Danmark
E-mail: dbrooks@clin.au.dk
Phone: +44 7379 544 322
Profile
My research involves the use of positron emission tomography and magnetic resonance imaging to help diagnose and study the progression of Alzheimer’s and Parkinson’s diseases and detect preclinical and prodromal cases. I am also interested in the role of inflammation in neurodegenerative disorders and the validation of imaging biomarkers for use in therapeutic trials.
Education
| 1998 | DSc (Medicine), University of London, UK |
|---|---|
| 1986 | MD, London University, UK |
| 1979 | MB BS University College Hospital Medical School, London, UK |
| 1972 | BA (Hons) Chemistry, 1st Class Oxford University, UK |
Appointments
| 2013 - present | Professor of Neurology, Dept of Nuclear Medicine, Aarhus University, Denmark |
|---|---|
| 2015- present | Professor of Neurology and PET Clinical Science, Newcastle University Translational and Clinical Research Institute (NUTCRI), UK |
| 1993 - 2015 | Hartnett Professor of Neurology, Imperial College London, UK |
Short Bibliographic Overview
Total number of peer-reviewed publications: 653 (Scopus)
Number of first authorships: 1 (2015-2020, Scopus)
Number of corresponding authorships: 7 (2015 - 2020, Scopus)
Number of citations: 71,287 (incl. self-citations, Scopus and SciVal)
H-index: 136 (Scopus and Scival 2015 - 2020)
Number of first authorships: 1 (2015-2020, Scopus)
Number of corresponding authorships: 7 (2015 - 2020, Scopus)
Number of citations: 71,287 (incl. self-citations, Scopus and SciVal)
H-index: 136 (Scopus and Scival 2015 - 2020)
Editorial Boards
| 2020 - present | Current Neuropharmacology (UK editor) |
|---|---|
| 2015 - 2020 | Molecular Imaging and Biology (Associate Editor) |
| 2012 - 2020 | Synapse, NPJ Parkinson's disease, Journal of Neuroimaging, Journal of Parkinson's disease, Brain (Associate Editor) |
Membership of UK Comittees
| 2016 - present | Alzheimer Research UK Grants Research Board |
|---|---|
| 2013 - 2018 | Alzheimer UK Biomedical Advisory Board |
| 2005 - 2008 | MRC Neurosciences and Mental Health Board |
| 2000 - 2003 | Wellcome Trust Neuroscience Panel |
| 1996 - 1997 | Chairman of Parkinson's UK Research Advisory Panel |
| 1995 - 2005 | Parkinson's UK Research Advisory Panel |
International Committees
| 2020 | JJND 2020 Panel Member: Novel imaging and brain stimulation methods and technologies related to Neurodegenerative Diseases |
|---|---|
| 2017 - 2020 | Chairing the ERC Neuroscience Panel (Advanced) |
| 2016 - present | Singapore NMRC International Advisory Board |
| 2007 - 2010 | German Dementia Kompetenz Network |
| 2004 - 2007 | German Parkinson Kompetenz Network |
| 2002 - 2006 | Scientific AB, Michael J. Fox Foundation |
| 1993 - 1997 | Director of International Society of Cerebral Blood Flow and Metabolism |
Memberships
| 2018 | Fellow European Academy of Neurology |
|---|---|
| 2001 | Fellow American Neurology Association |
| 2001 | Fellow Academy of Medical Sciences UK (FMedSci) |
| 1993 | Fellow Royal College of Physicians, UK |
| 1982 | Member of Royal College of Physicians, UK |
Recent Funding
| 2022 - 2022 | Parkinsonforeningen: Can high-intensity aerobic exercice increase brain synaptic SV2A protein density in Parkinson disease patients? A PET-MRI study DKK 100,000 |
|---|---|
| 2022 - 2025 | Vilhelm Pedersen og Hustrus Mindelegat: Can high-intensity arerobic exercise increase brain synaptic SV2A protein density in Parkinson disease patients? A PET MRI study DKK 2.8m |
| 2018 - 2022 | EU Horizon 2020: AD Detect Prevent (with Oxford and Nottingham Universities and Brain+) DKK 2.2m |
| 2017 - 2020 | Danish Council for Independent Research: Noradrenergic dysfunction and slowing of cortical oscillatory activity in Parkinson's disease patients with mild cognitive impairment DKK 3m |
| 2017 - 2020 | Lundbeck Foundation: Imaging synaptic dysfunction in a rodent model of Parkinson's disease based on toxin-induced glucocerebrosidase A deficiency DKK 1.6m |
| 2018 - 2020 | Eurostars/Danish Innovation Fund: Alzheimer Shield (with Karolinska Institute and Brain+ DKK 641,000 |
Medal Lectures / Awards
| October 2017 | Ramon Y Cajal Award, Spanish Academy of Medicine, Madrid, Spain |
|---|---|
| 2016 | Danish Alzheimer Association Award, Copenhagen, Denmark |
| 2005 | Kuhl Lassen Award, Society of Nuclear Medicine, Toronto, Canada |
| March 2004 | Charles E Wilson Lecture, The Psychobiology Institute, Jerusalem, Israel |
| 2003 | Cotzias Lecture, Spanish Society of Neurology, Barcelona, Spain |
| November 2002 | Stanley Fahn Lecture, 7th International Congress of Parkinson's Disease and Movement Disorders, Miami, USA |